In this four year two phase (R21/R33) project we will apply advanced proteomic and metabolomic nanoflow liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry technologies in the study of both plasma and serum from Type 1 diabetes patients and isolated human pancreatic islets. The overall approach endeavors to advance the study of Type 1 diabetes and human islet transplantation by identifying biomarkers at the level of the proteome and metabolome that are predictive of both Type 1 diabetes and islet performance in vivo. Our approach will utilize proteome-wide stable isotope labeling of peptides, as well as quantitative cysteine-peptide enrichment technology (QCET) and N-linked glycopeptide enrichment strategies to obtain broad proteome coverage and enhance quantitation. We will also utilize very low nanoflow LC separations to minimize ionization suppression and eliminate background ions originating from the solvent, thereby improving normalization of metabolite peak intensities and improve quantitation. This approach will be capable of rapidly identifying and measuring expression levels for thousands of peptides or concentrations of metabolites in a single analysis. Phase 1 of this project will (a) define the sample processing and LC separation conditions necessary for broad metabolome and proteome coverage in human plasma/serum and pancreatic islets, (b) establish accurate mass and time tag databases for both peptides and metabolites detected in human plasma/serum and pancreatic islets, and (c) demonstrate the ability of the technology to distinguish plasma/serum from healthy control or recently diagnosed Type 1 diabetic patients. The refinement of this technological approach will provide the basis for high throughput studies of large numbers of samples. The application of this technology in Phase 2 of the project will involve (a) the high throughput studies of complete sample sets from the Diabetes Autoantibody Standardization Program (DASP), (b) validation of potential biomarkers via analysis of a blind DASP sample set, and (c) comparative studies of multiple human pancreatic islet preparations to identify potential biomarkers predictive of islet performance in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants Phase II (R33)
Project #
5R33DK070146-04
Application #
7455195
Study Section
Special Emphasis Panel (ZDK1-GRB-9 (O1))
Program Officer
Sechi, Salvatore
Project Start
2004-09-30
Project End
2010-06-30
Budget Start
2008-07-01
Budget End
2010-06-30
Support Year
4
Fiscal Year
2008
Total Cost
$647,122
Indirect Cost
Name
Battelle Pacific Northwest Laboratories
Department
Type
DUNS #
032987476
City
Richland
State
WA
Country
United States
Zip Code
99352
Webb-Robertson, Bobbie-Jo M; Matzke, Melissa M; Metz, Thomas O et al. (2013) Sequential projection pursuit principal component analysis--dealing with missing data associated with new -omics technologies. Biotechniques 54:165-8
Zhang, Qibin; Fillmore, Thomas L; Schepmoes, Athena A et al. (2013) Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. J Exp Med 210:191-203
Schrimpe-Rutledge, Alexandra C; Fontès, Ghislaine; Gritsenko, Marina A et al. (2012) Discovery of novel glucose-regulated proteins in isolated human pancreatic islets using LC-MS/MS-based proteomics. J Proteome Res 11:3520-32
Gonzalez, Rachel M; Zhang, Qibin; Zangar, Richard C et al. (2011) Development of a fibrinogen-specific sandwich enzyme-linked immunosorbent assay microarray assay for distinguishing between blood plasma and serum samples. Anal Biochem 414:99-102
Sorensen, Christina M; Ding, Jie; Zhang, Qibin et al. (2010) Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subset. Clin Biochem 43:948-56
Alquier, Thierry; Peyot, Marie-Line; Latour, Martin G et al. (2009) Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets. Diabetes 58:2607-15
Karpievitch, Yuliya; Stanley, Jeff; Taverner, Thomas et al. (2009) A statistical framework for protein quantitation in bottom-up MS-based proteomics. Bioinformatics 25:2028-34
Ding, Jie; Sorensen, Christina M; Jaitly, Navdeep et al. (2008) Application of the accurate mass and time tag approach in studies of the human blood lipidome. J Chromatogr B Analyt Technol Biomed Life Sci 871:243-52
Metz, Thomas O; Qian, Wei-Jun; Jacobs, Jon M et al. (2008) Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. J Proteome Res 7:698-707
Metz, Thomas O; Zhang, Qibin; Page, Jason S et al. (2007) The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomark Med 1:159-185